Enzymatica AB Interim report Q3/2022: A broader role for ColdZyme adds potential for the future ...Middle East

LUND, Sweden, Nov. 2, 2022 /PRNewswire/ -- Significant events during the quarter Significant events after the quarter · To ensure the long-term financing of the business, in September the company raised about SEK 74.7 million before issue expenses through a rights issue. The rights issue...

Read More Details
Finally We wish PressBee provided you with enough information of ( Enzymatica AB Interim report Q3/2022: A broader role for ColdZyme adds potential for the future )

Also on site :

• Here are 12 ‘No Kings’ protests against Trump set for June 14 across Southern California
• Trump Steps Out for Rare Date Night With Melania Amid ICE Protests
• Country Icon Is Nearly Unrecognizable Returning From Years-Long Hiatus